E-LIB Suche - Ergebnisse für: Yasuda, Nobuyuki

1

The Fractalkine‐CX3CR1 Axis Regulates Non‐inflammatory Oste..:

Kuboi, Yoshikazu ; Kuroda, Yukiko ; Ohkuro, Masayoshi...
JBMR Plus. 6 (2022) 10 - p. , 2022

Link: https://doi.org/10.1002/..

2

Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclona..:

Tanaka, Yoshiya ; Takeuchi, Tsutomu ; Yamanaka, Hisashi...
Arthritis & Rheumatology. 73 (2021) 4 - p. 587-595 , 2021

Link: https://doi.org/10.1002/..

3

Emerging Role of Fractalkine in the Treatment of Rheumatic ..:

Tanaka, Yoshiya ; Hoshino-Negishi, Kana ; Kuboi, Yoshikazu...
ImmunoTargets and Therapy. 9 (2020) - p. 241-253 , 2020

Link: https://doi.org/10.2147/..

4

Role of Anti‐Fractalkine Antibody in Suppression of Joint D..:

Hoshino‐Negishi, Kana ; Ohkuro, Masayoshi ; Nakatani, Tomoya...
Arthritis & Rheumatology. 71 (2019) 2 - p. 222-231 , 2019

Link: https://doi.org/10.1002/..

5

Comparative Law and Globalization in Asian Perspectives: Tw..:

, In: The Indian Yearbook of Comparative Law; The Indian Yearbook of Comparative Law 2018,

Yasuda, Nobuyuki - p. 3-44 , 2019

Link: https://doi.org/10.1007/..

6

Blockade of the fractalkine–CX3CR1 axis ameliorates experim..:

Kuboi, Yoshikazu ; Nishimura, Miyuki ; Ikeda, Wataru...
International Immunology. 31 (2019) 5 - p. 287-302 , 2019

Link: https://doi.org/10.1093/..

7

Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a ..:

Tabuchi, Hiroko ; Katsurabara, Toshinori ; Mori, Masahiko...
The Journal of Clinical Pharmacology. 59 (2018) 5 - p. 688-701 , 2018

Link: https://doi.org/10.1002/..

8

Therapeutic intervention of inflammatory/immune diseases by..:

Imai, Toshio ; Yasuda, Nobuyuki
Inflammation and Regeneration. 36 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

9

Anti-CX3CL1 monoclonal antibody: A promising therapy for sy..:

Luong, Vu H. ; Chino, Takenao ; Tokuriki, Atsushi...
Journal of Dermatological Science. 84 (2016) 1 - p. e111-e112 , 2016

Link: https://doi.org/10.1016/..

10

Mo1682 Inflammation via the Fractalkine (CX3CL1)/CX3CR1 Pat..:

Motoi, Sotaro ; Ohkuro, Masayoshi ; Ikeda, Wataru...
Gastroenterology. 148 (2015) 4 - p. S-684 , 2015

Link: https://doi.org/10.1016/..

11

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics..:

Takeuchi, Yutaka ; Namiki, Masayuki ; Kitahara, Yasumi...
Pharmacology & Pharmacy. 4 (2013) 9 - p. 663-678 , 2013

Link: https://doi.org/10.4236/..

12

Does N-Acetylcysteine Reduce the Incidence of Contrast-Indu..:

Tanaka, Akihito ; Suzuki, Yoriyasu ; Suzuki, Noriyuki...
Internal Medicine. 50 (2011) 7 - p. 673-677 , 2011

Link: https://doi.org/10.2169/..

13

Comparison of Medically Versus Surgically Treated Acute Typ..:

Yanagisawa, Satoshi ; Yuasa, Takeshi ; Suzuki, Noriyuki...
The American Journal of Cardiology. 108 (2011) 3 - p. 453-459 , 2011

Link: https://doi.org/10.1016/..

14

The Characteristic of Premature Ventricular Complex from Ri..:

Hirai, Toshihisa ; Saka, Yuuki ; Ikai, Yoshihiro...
Journal of Arrhythmia. 27 (2011) Supplement - p. PJ2_089 , 2011

Link: https://doi.org/10.4020/..

15

Clinical outcomes and prognostic factor for acute heart fai..:

Yanagisawa, Satoshi ; Miki, Ken ; Yasuda, Nobuyuki...
International Journal of Cardiology. 145 (2010) 3 - p. 574-576 , 2010

Link: https://doi.org/10.1016/..